POWERING THE PREVENTION SHIFT
The CVDACTION Impact Model
A realistic step change improvement in secondary prevention will prevent 61,000 heart attacks, strokes and other serious events in 3 years, free up 460,000 bed days (that's 2 hospitals emptied for a year) and deliver rapid return on investment generating £2.5 billion in savings.
The CVDACTION Impact Model estimates the impact on health outcomes, NHS and social care demand, economic productivity and return on investment for England and every Integrated Care Board when secondary prevention treatment is optimised at scale.
4 high risk conditions:
-
High blood pressure
-
High cholesterol
-
Diabetes
-
Chronic Kidney Disease
4 high impact treatments that are NICE recommended but substantially underused:
-
Blood Pressure lowering
-
Cholesterol lowering
-
Renal Angiotensin Agents
-
SGLT2 inhibitors
3 scenarios:
-
Step Change is the minimum realistic near-term improvement level - using CVDACTION to find patients on suboptimal therapy and optimise treatment within routine workflows.
-
Advanced represents substantial improvement on the way to Full Uptake.
-
Full Uptake is a theoretical 100% optimisation (not achievable in practice as medicines not always suitable for patients)
The CVDACTION Impact Model was developed by Economics By Design and Get the Data on behalf of Into-Action.Health.
AstraZeneca provided a grant towards this independent project and has not been involved in its creation or organisation.
